1 |
CimziaReferencer Fleiscmann R et al. Efficacy and Safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing prevoius disease-modifying antirheumatic therapy: the FAST4WARD study. Ann Rheum Dis 2009;68:805-11. Keystone E et al: Certolizumab Pegol Plus Methotrexate Is Significantly More Effective Than Placebo Plus [..]
|
<< Bydureon | Daxas >> |